Combination of immunosuppressive drugs leaves specific " fingerprint" on gene expression in vitro in vitro

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 2, 2009, Pages 283-292

  Rumberger, Brigitta ^a   Kreutz, Clemens ^b   Nickel, Christian ^a   Klein, Marinella ^a   Lagoutte, Severine ^a   Teschner, Sven ^a   Timmer, Jens ^b   Gerke, Peter ^a   Walz, Gerd ^a   Donauer, Johannes ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOSPORIN A; DNA; EVEROLIMUS; INTERLEUKIN 2; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA FINGERPRINTING; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MARKER GENE; ORGAN TRANSPLANTATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; DRUG EFFECTS; DRUG INTERACTION; GENE EXPRESSION; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION;

ADULT; CELLS, CULTURED; CYCLOSPORINE; DRUG INTERACTIONS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MYCOPHENOLIC ACID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIROLIMUS; TACROLIMUS;

EID: 70350675363     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970802626268     Document Type: Article

References (26)

1. Hernandez-Fuentes, M.P.; Warrens, A.N.; Lechler, R.I. Immunologic monitoring. Immunol Rev. 2003, 196, 247-264.
2. Barten, M.J.; Streit, F.; Boeger, M. et al. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. Transplantation. 2004, 77, 1154-1162.
3. Flores, M.G.; Zhang, S.; Ha, A. et al. In vitro evaluation of the effects of candidate immunosuppressive drugs: Flow cytometry and quantitative real-time PCR as two independent and correlated read-outs. J Immunol Methods. 2004, 289, 123-135.
4. Ellisen, L.W.; Palmer, R.E.; Maki, R.G. et al. Cascades of transcriptional induction during human lymphocyte activation. Eur J Cell Biol. 2001, 0, 321-328.
5. Fujino, M.; Kitazawa, Y.; Kawasaki, M. et al. Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats. Liver Transpl. 2004, 10, 379-391.
6. Erickson, L.M.; Pan, F.; Ebbs, A.; Kobayashi, M.; Jiang, H. Microarray-based gene expression profiles of allograft rejection and immunosuppression in the rat heart transplantation model. Transplantation. 2003, 76, 582-588.
7. Sarwal, M.; Chua, M.S.; Kambham, N. et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med. 2003, 349, 125-138. (Pubitemid 36818782)
8. Donauer, J.; Rumberger, B.; Klein, M. et al. Expression profiling on chronically rejected transplant kidneys. Transplantation. 2003, 76, 539-547.
9. Lamb, J.; Crawford, E.D.; Peck, D. et al. The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006, 313, 1929-1935
10. Boldrick, J.C.; Alizadeh, A.A.; Diehn, M. et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci USA. 2002, 99, 972-977.
11. Khanna, A.K. Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. Transplantation. 2000, 70, 690-694.
12. Barten, M.J.; Gummert, J.F.; van Gelder, T.; Shorthouse, R.; Morris, R.E. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: Inhibition by immunosuppressive drugs in vitro. J Immunol Methods. 2001, 253, 95-112.
13. Wright, D.C.; Deol, H.S.; Tuch, B.E. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents. Transpl Immunol. 1999, 7, 141-147.
14. Eisen, M.B.; Brown, P.O. DNA arrays for analysis of gene expression. Methods Enzymol. 1999, 303, 179-205.
15. Brazma, A.; Hingamp, P.; Quackenbush, J. et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 2001, 29, 365-371.
16. Workman, C.; Jensen, L.J.; Jarmer, H. et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 2002, 0023, research0048.
17. Benjamini, Y.; Drai, D.; Elmer, G.; Kafkafi, N.; Golani, I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001, 125, 279-284.
18. Kaufman, L.; Rousseeuw, P. Finding Groups in Data: An Introduction to Cluster Analysis. John Wiley Sciences, New York, 1990.
19. Schroppel, B.; Zhang, N.; Chen, P. et al. Murphy, Differential expression of chemokines and chemokine receptors in murine isl et allografts: The role of CCR2 and CCR5 signaling pathways. J Am Soc Nephrol. 2004, 15, 1853-1861.
20. Dudley, J.; Truman, C.; McGraw, M.; Tizard, J.; Haque, G.; Bradley, B. Estimation of individual sensitivity to cyclosporin in children awaiting renal transplantation. Nephrol Dial Transplant. 2003, 18, 403-410.
21. Cristillo, A.D.; Bierer, B.E. Identification of novel targets of immunosuppressive agents by cDNA-based microarray analysis. J Biol Chem. 2002, 277, 4465-4476.
22. Libetta, C.; Sepe, V.; Zucchi, M. et al. The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo. Kidney Int. 2007, 72, 114-120
23. Jin, S.; Mathis, A.S.; Rosenblatt, J. et al. Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: Macrophage scavenger receptor regulation. Transplantation. 2004, 77, 497-504.
24. Jin, S.; Mathis, A.S.; Gioia, K. et al. Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages. Transplantation. 2004, 77, 1281-1287.
25. Castro, C.; Campistol, J.M.; Sancho, D.; Sanchez-Madrid, F.; Casals, E.; Andres, V. Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1-independent pathway. Atherosclerosis. 2004, 172, 31-38.
26. Mathis, A.S.; Jin, S.; Friedman, G.S.; Peng, F.; Carl, S.M.; Knipp, G.T. The pharmacodynamic effects of sirolimus and sirolimus-calcineurin inhibitor combinations on macrophage scavenger and nuclear hormone receptors. J Pharm Sci. 2007, 96, 209-222